Perceptive Advisors as of June 30, 2022
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 111 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Travere Therapeutics Note 2.250% 3/0 (Principal) | 14.3 | $456M | 45M | 10.13 | |
Amicus Therapeutics (FOLD) | 9.0 | $289M | 27M | 10.74 | |
Mirati Therapeutics | 6.0 | $193M | 2.9M | 67.13 | |
Cerevel Therapeutics Hldng I (CERE) | 4.2 | $135M | 5.1M | 26.44 | |
Iovance Biotherapeutics (IOVA) | 4.1 | $131M | 12M | 11.04 | |
Lianbio Sponsored Ads (LIANY) | 3.8 | $122M | 57M | 2.16 | |
Crinetics Pharmaceuticals In (CRNX) | 3.1 | $99M | 5.3M | 18.65 | |
Global Blood Therapeutics In | 3.0 | $96M | 3.0M | 31.95 | |
Springworks Therapeutics (SWTX) | 3.0 | $95M | 3.9M | 24.62 | |
Amylyx Pharmaceuticals (AMLX) | 2.1 | $68M | 3.5M | 19.26 | |
Xenon Pharmaceuticals (XENE) | 2.0 | $65M | 2.1M | 30.42 | |
Meiragtx Holdings (MGTX) | 1.7 | $53M | 7.0M | 7.57 | |
Lyra Therapeutics (LYRA) | 1.6 | $52M | 9.1M | 5.65 | |
Bellus Health Com New | 1.6 | $51M | 5.5M | 9.24 | |
Prometheus Biosciences | 1.5 | $48M | 1.7M | 28.23 | |
Albireo Pharma | 1.5 | $47M | 2.4M | 19.86 | |
Cincor Pharma | 1.4 | $44M | 2.3M | 18.84 | |
Vbi Vaccines Inc Cda Com New | 1.3 | $42M | 52M | 0.81 | |
Seagen | 1.2 | $40M | 224k | 176.94 | |
Female Health (VERU) | 1.2 | $40M | 3.5M | 11.30 | |
Aldeyra Therapeutics (ALDX) | 1.2 | $40M | 9.9M | 3.99 | |
Neurocrine Biosciences (NBIX) | 1.2 | $39M | 398k | 97.48 | |
Rapt Therapeutics (RAPT) | 1.1 | $35M | 1.9M | 18.25 | |
Relay Therapeutics (RLAY) | 1.0 | $33M | 1.9M | 16.75 | |
Eli Lilly & Co. (LLY) | 1.0 | $32M | 100k | 324.23 | |
Coherus Biosciences Note 1.500% 4/1 (Principal) | 0.9 | $30M | 4.5M | 6.55 | |
Cogent Biosciences (COGT) | 0.9 | $28M | 3.1M | 9.02 | |
Coherus Biosciences (CHRS) | 0.8 | $26M | 3.6M | 7.24 | |
Madrigal Pharmaceuticals (MDGL) | 0.8 | $26M | 368k | 71.58 | |
Alnylam Pharmaceuticals (ALNY) | 0.8 | $25M | 173k | 145.85 | |
Nautilus Biotechnology (NAUT) | 0.8 | $25M | 9.1M | 2.69 | |
Procept Biorobotics Corp (PRCT) | 0.8 | $25M | 750k | 32.69 | |
Adma Biologics (ADMA) | 0.7 | $23M | 12M | 1.98 | |
Nuvalent Inc-a (NUVL) | 0.7 | $22M | 1.7M | 13.56 | |
Establishment Labs Holdings Ord (ESTA) | 0.7 | $22M | 406k | 54.38 | |
Zymeworks | 0.7 | $22M | 4.1M | 5.30 | |
Immatics SHS (IMTX) | 0.7 | $22M | 2.5M | 8.71 | |
Inhibrx | 0.7 | $22M | 1.9M | 11.35 | |
Arcellx Common Stock (ACLX) | 0.6 | $21M | 1.1M | 18.08 | |
Iveric Bio | 0.6 | $20M | 2.1M | 9.62 | |
Harmony Biosciences Hldgs In (HRMY) | 0.6 | $20M | 412k | 48.77 | |
Tarsus Pharmaceuticals (TARS) | 0.6 | $19M | 1.3M | 14.60 | |
CryoLife (AORT) | 0.5 | $18M | 930k | 18.88 | |
Dice Therapeutics | 0.5 | $16M | 1.1M | 15.52 | |
Rocket Pharmaceuticals (RCKT) | 0.5 | $16M | 1.2M | 13.76 | |
Bridgebio Pharma (BBIO) | 0.5 | $15M | 1.7M | 9.08 | |
BioMarin Pharmaceutical (BMRN) | 0.5 | $15M | 180k | 82.87 | |
Outset Med (OM) | 0.5 | $15M | 999k | 14.86 | |
Athira Pharma (ATHA) | 0.5 | $15M | 4.8M | 3.05 | |
Apellis Pharmaceuticals (APLS) | 0.5 | $15M | 321k | 45.22 | |
Travere Therapeutics (TVTX) | 0.4 | $14M | 570k | 24.23 | |
Rain Therapeutics | 0.4 | $14M | 2.5M | 5.56 | |
Singular Genomics Systems In | 0.4 | $14M | 3.5M | 3.82 | |
Treace Med Concepts (TMCI) | 0.4 | $14M | 941k | 14.34 | |
Verona Pharma Sponsored Ads (VRNA) | 0.4 | $12M | 2.9M | 4.19 | |
Miragen Therapeutics (VRDN) | 0.4 | $11M | 972k | 11.57 | |
Chemocentryx | 0.3 | $11M | 442k | 24.78 | |
Caremax Com Cl A | 0.3 | $11M | 3.0M | 3.63 | |
Landos Biopharma | 0.3 | $11M | 15M | 0.73 | |
Day One Biopharmaceuticals I (DAWN) | 0.3 | $10M | 556k | 17.90 | |
Verrica Pharmaceuticals (VRCA) | 0.3 | $9.7M | 5.0M | 1.92 | |
Leap Therapeutics | 0.3 | $9.1M | 8.0M | 1.15 | |
Concert Pharmaceuticals I equity | 0.3 | $9.1M | 2.2M | 4.21 | |
Isoplexis Corp | 0.3 | $8.8M | 4.1M | 2.16 | |
Kronos Bio (KRON) | 0.3 | $8.8M | 2.4M | 3.64 | |
Hillevax (HLVX) | 0.3 | $8.4M | 765k | 10.93 | |
Solid Biosciences | 0.3 | $8.3M | 13M | 0.62 | |
Privia Health Group (PRVA) | 0.2 | $8.0M | 273k | 29.12 | |
Revance Therapeutics (RVNC) | 0.2 | $7.9M | 573k | 13.82 | |
Morphic Hldg (MORF) | 0.2 | $7.9M | 363k | 21.70 | |
Spdr Ser Tr S&p Biotech Put Option (XBI) | 0.2 | $7.4M | 100k | 74.27 | |
Point Biopharma Global | 0.2 | $7.3M | 1.1M | 6.81 | |
Somalogic Class A Com | 0.2 | $6.8M | 1.5M | 4.52 | |
Health Catalyst (HCAT) | 0.2 | $6.7M | 465k | 14.49 | |
Sema4 Holdings Corp Com Cl A | 0.2 | $6.3M | 5.0M | 1.26 | |
Icosavax | 0.2 | $6.0M | 1.0M | 5.73 | |
C4 Therapeutics Com Stk (CCCC) | 0.2 | $5.8M | 766k | 7.54 | |
Nuvation Bio Com Cl A (NUVB) | 0.2 | $5.7M | 1.8M | 3.24 | |
Athenex | 0.2 | $5.5M | 14M | 0.41 | |
Aclaris Therapeutics (ACRS) | 0.1 | $4.8M | 341k | 13.96 | |
Nanobiotix Sponsored Ads (NBTX) | 0.1 | $4.0M | 1.1M | 3.80 | |
Quotient SHS | 0.1 | $3.9M | 16M | 0.24 | |
Astria Therapeutics (ATXS) | 0.1 | $3.8M | 1.3M | 3.00 | |
Pyxis Oncology Common Stock (PYXS) | 0.1 | $3.6M | 1.5M | 2.38 | |
Macrogenics (MGNX) | 0.1 | $3.6M | 1.2M | 2.95 | |
Tyra Biosciences (TYRA) | 0.1 | $3.5M | 494k | 7.15 | |
Clover Health Investments Com Cl A (CLOV) | 0.1 | $3.2M | 1.5M | 2.14 | |
Y Mabs Therapeutics (YMAB) | 0.1 | $3.2M | 212k | 15.13 | |
Science 37 Holdings | 0.1 | $3.0M | 1.5M | 2.01 | |
Absci Corp (ABSI) | 0.1 | $3.0M | 894k | 3.32 | |
Envveno Medical (NVNO) | 0.1 | $3.0M | 782k | 3.78 | |
Cassava Sciences Put Option (SAVA) | 0.1 | $2.8M | 100k | 28.12 | |
Fusion Pharmaceuticals | 0.1 | $2.6M | 1.1M | 2.49 | |
Hyperfine Com Cl A (HYPR) | 0.1 | $2.5M | 1.1M | 2.23 | |
Acumen Pharmaceuticals (ABOS) | 0.1 | $2.4M | 509k | 4.70 | |
Relmada Therapeutics (RLMD) | 0.1 | $2.3M | 121k | 18.99 | |
Dariohealth Corp Com New (DRIO) | 0.1 | $2.0M | 328k | 6.14 | |
Fulcrum Therapeutics (FULC) | 0.0 | $1.4M | 294k | 4.90 | |
Pear Therapeutics Class A Com | 0.0 | $1.4M | 901k | 1.54 | |
Ferrari Nv Ord (RACE) | 0.0 | $1.1M | 6.2k | 183.55 | |
Sonendo (SONX) | 0.0 | $1.1M | 649k | 1.72 | |
Zymergen | 0.0 | $1.1M | 883k | 1.23 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $850k | 290k | 2.93 | |
Agile Therapeutics Com New | 0.0 | $620k | 532k | 1.16 | |
Motus Gi Hldgs Incorporated | 0.0 | $507k | 1.8M | 0.28 | |
Provention Bio | 0.0 | $443k | 111k | 4.00 | |
Eqrx *w Exp 12/17/202 | 0.0 | $203k | 250k | 0.81 | |
Neptune Wellness Solutions I Com New | 0.0 | $81k | 57k | 1.42 | |
Caremax *w Exp 06/08/202 | 0.0 | $43k | 60k | 0.72 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $32k | 167k | 0.19 | |
Surrozen | 0.0 | $18k | 6.0k | 2.99 |